The possible role of genetic testing in the early identification of patients at increased risk of developing anthracycline-induced cardiotoxicity
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.0885
Abstract: In the last years prognosis of cancer patients (pts) has been improved, but the develop of cardiotoxicity (CTX) in pts with low CV risk treated with cumulative doses of Anthracycline (ANT) considered safe, led to… read more here.
Keywords: risk; tni group; group; probnp group ... See more keywords